• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子建模与原子水平洞察 MmpL3 Mtb 的结合机制。

Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb.

机构信息

Department of Biomedical Engineering, School of Engineering Sciences, College of Basic & Applied Sciences, University of Ghana, PMB LG 77, Legon, 0000, Accra, Ghana.

West African Center for Cell Biology of Infectious Pathogens, Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, 0000, Accra, Ghana.

出版信息

Chem Biodivers. 2022 Sep;19(9):e202200160. doi: 10.1002/cbdv.202200160. Epub 2022 Aug 31.

DOI:10.1002/cbdv.202200160
PMID:35969844
Abstract

Mycobacterial membrane proteins Large (MmpLs), which belong to the resistance, nodulation, and division (RND) protein superfamily, play critical roles in transporting polymers, lipids, and immunomodulators. MmpLs have become one of the important therapeutic drug targets to emerge in recent times. In this study, two homology modelling techniques, Modeller and SWISS-MODEL, were used in modelling the three-dimensional protein structure of the MmpL3 of Mycobacterium tuberculosis using that of M. smegmatis as template. MmpL3 inhibitors, namely BM212, NITD304, SPIRO, and NITD349, in addition to the co-crystalized ligands AU1235, ICA38, SQ109 and rimonabant, were screened against the modelled structure and the Mmpl3 of M. smegmatis using molecular docking techniques. Protein-ligand interactions were analysed using molecular dynamics simulations and Molecular Mechanics Poisson-Boltzmann surface area computations. Novel residues Gln32, Leu165, Ile414, and Phe35 were identified as critical for binding to M. tuberculosis MmpL3, and conformational dynamics upon inhibitor binding were discussed.

摘要

分枝杆菌膜蛋白 Large(MmpL)属于抗性、结节和分裂(RND)蛋白超家族,在聚合物、脂质和免疫调节剂的运输中发挥关键作用。MmpL 已成为近年来出现的重要治疗药物靶点之一。在这项研究中,使用了两种同源建模技术,Modeller 和 SWISS-MODEL,使用 M. smegmatis 的结构作为模板,对结核分枝杆菌的 MmpL3 的三维蛋白质结构进行建模。使用分子对接技术筛选了 MmpL3 抑制剂(如 BM212、NITD304、SPIRO 和 NITD349)以及共晶配体 AU1235、ICA38、SQ109 和利莫那班,针对建模结构和 M. smegmatis 的 Mmpl3 进行了筛选。使用分子动力学模拟和分子力学泊松-玻尔兹曼表面面积计算分析了蛋白质-配体相互作用。鉴定了新的残基 Gln32、Leu165、Ile414 和 Phe35 对结合结核分枝杆菌 MmpL3 是关键的,并讨论了抑制剂结合时的构象动力学。

相似文献

1
Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb.分子建模与原子水平洞察 MmpL3 Mtb 的结合机制。
Chem Biodivers. 2022 Sep;19(9):e202200160. doi: 10.1002/cbdv.202200160. Epub 2022 Aug 31.
2
Computational design of MmpL3 inhibitors for tuberculosis therapy.用于结核病治疗的MmpL3抑制剂的计算设计
Mol Divers. 2023 Feb;27(1):357-369. doi: 10.1007/s11030-022-10436-2. Epub 2022 Apr 28.
3
Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.对结核分枝杆菌中多种药效基团靶点MmpL3抑制机制的新见解。
Antimicrob Agents Chemother. 2014 Nov;58(11):6413-23. doi: 10.1128/AAC.03229-14. Epub 2014 Aug 18.
4
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target.膜转运蛋白 MmpL3 的晶体结构,一种抗结核药物靶点。
Cell. 2019 Jan 24;176(3):636-648.e13. doi: 10.1016/j.cell.2019.01.003.
5
Specifically Targeting Mtb Cell-Wall and TMM Transporter: The Development of MmpL3 Inhibitors.具体针对结核分枝杆菌细胞壁和 TMM 转运蛋白:MmpL3 抑制剂的开发。
Curr Protein Pept Sci. 2021 Oct 26;22(4):290-303. doi: 10.2174/1389203722666210421105733.
6
A piperidinol-containing molecule is active against by inhibiting the mycolic acid flippase activity of MmpL3.一种含有哌啶醇的分子通过抑制 MmpL3 的分枝菌酸翻转酶活性对有活性。
J Biol Chem. 2019 Nov 15;294(46):17512-17523. doi: 10.1074/jbc.RA119.010135. Epub 2019 Sep 27.
7
Allosteric coupling of substrate binding and proton translocation in MmpL3 transporter from .基质结合和质子转运的变构偶联在. 中的 MmpL3 转运蛋白中
mBio. 2024 Oct 16;15(10):e0218324. doi: 10.1128/mbio.02183-24. Epub 2024 Aug 30.
8
Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3.靶向分枝菌酸转运蛋白MmpL3的抗分枝杆菌药物先导物的基于结构的设计。
Structure. 2022 Oct 6;30(10):1395-1402.e4. doi: 10.1016/j.str.2022.07.009. Epub 2022 Aug 17.
9
1-Benzo[]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis.苯并咪唑衍生物影响结核分枝杆菌中的 MmpL3。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00441-19. Print 2019 Oct.
10
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.通过非靶向和靶向突变筛选鉴定新型 MmpL3 抑制剂,定义具有不同耐药性的 MmpL3 结构域。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00547-19. Print 2019 Oct.

引用本文的文献

1
Targeting using natural African compounds as promising agents for managing diabetic complications.以天然非洲化合物为靶向,作为治疗糖尿病并发症的有前景药物。
Front Bioinform. 2025 Feb 6;5:1499255. doi: 10.3389/fbinf.2025.1499255. eCollection 2025.
2
Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors.利什曼原虫主要蝶啶还原酶抑制剂的天然产物鉴定及分子对接研究
Pharmaceuticals (Basel). 2024 Dec 24;18(1):6. doi: 10.3390/ph18010006.
3
Machine learning and molecular docking prediction of potential inhibitors against dengue virus.
登革病毒潜在抑制剂的机器学习与分子对接预测
Front Chem. 2024 Dec 24;12:1510029. doi: 10.3389/fchem.2024.1510029. eCollection 2024.
4
Developing novel indoles as antitubercular agents and simulated annealing-based analysis of their binding with MmpL3.开发新型吲哚作为抗结核药物及其与MmpL3结合的基于模拟退火的分析。
Future Med Chem. 2025 Jan;17(1):19-34. doi: 10.1080/17568919.2024.2444872. Epub 2024 Dec 25.
5
Impact of MSMEG5257 Deletion on Growth.MSMEG5257基因缺失对生长的影响。
Microorganisms. 2024 Apr 11;12(4):770. doi: 10.3390/microorganisms12040770.
6
Target Identification in Anti-Tuberculosis Drug Discovery.抗结核药物发现中的靶点鉴定。
Int J Mol Sci. 2023 Jun 22;24(13):10482. doi: 10.3390/ijms241310482.